Jan Westerblad

General Manager, Nordic Region at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Jan Westerblad's Colleagues at Alnylam Pharmaceuticals
Alexandre Chru

Product Manager Patisiran/Givosiran

Contact Alexandre Chru

PHILIPPA QUIGLEY

Medical Science Liaison - Rare Diseases

Contact PHILIPPA QUIGLEY

Sandra Kollmann

Executive Assistant Commercial CEMEA

Contact Sandra Kollmann

Paolo MBA

National Medical Science Liaison Italy - Biotech- siRNA Gene Silencing - Rare Diseases

Contact Paolo MBA

Bilal Brans

Physiologiste du sport

Contact Bilal Brans

View All Jan Westerblad's Colleagues
Jan Westerblad's Contact Details
HQ
(617) 551-8200
Location
Company
Alnylam Pharmaceuticals
Jan Westerblad's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Jan Westerblad
Jan Westerblad currently works for Alnylam Pharmaceuticals.
Jan Westerblad's role at Alnylam Pharmaceuticals is General Manager, Nordic Region.
Jan Westerblad's email address is ***@alnylam.com. To view Jan Westerblad's full email address, please signup to ConnectPlex.
Jan Westerblad works in the SaaS industry.
Jan Westerblad's colleagues at Alnylam Pharmaceuticals are Alexandre Chru, PHILIPPA QUIGLEY, Sandra Kollmann, Paolo MBA, Bilal Brans, Harith Ali, Colleen Coxson and others.
Jan Westerblad's phone number is (617) 551-8200
See more information about Jan Westerblad